financetom
Business
financetom
/
Business
/
Aldabra 4 Liquidity Opportunity Vehicle, Inc. Announces Pricing of $261 Million Initial Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aldabra 4 Liquidity Opportunity Vehicle, Inc. Announces Pricing of $261 Million Initial Public Offering
Mar 11, 2026 1:18 AM

MIAMI, Jan. 21, 2026 /PRNewswire/ -- Aldabra 4 Liquidity Opportunity Vehicle, Inc. (the "Company"), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, announced the pricing of its initial public offering of 26,100,000 units at a price of $10.00 per unit on January 21, 2026. The units are expected to be listed for trading on the Nasdaq Global Market under the ticker symbol "ALOVU" beginning January 22, 2026. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on the Nasdaq Global Market under the symbols "ALOV" and "ALOVW," respectively. The offering is expected to close on January 23, 2026, subject to customary closing conditions.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering. Ladenburg Thalmann & Co. and The Benchmark Company, LLC are acting as co-managers. The Company has granted the underwriters a 45-day option to purchase up to 3,915,000 additional units at the initial public offering price to cover over-allotments, if any. Chardan is acting as advisor to the Company.

The public offering is being made only by means of a prospectus. When available, copies of the prospectus relating to the offering may be obtained from Cantor Fitzgerald & Co., 499 Park Avenue, New York, New York 10022, Attention: General Counsel, or by email at: [email protected].

A registration statement relating to the securities became effective on January 21, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds from the offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the Company will ultimately complete a business combination transaction. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the Company's offering filed with the U.S. Securities and Exchange Commission (the "SEC"). Copies of these documents are available on the SEC's website, at www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact

Aldabra 4 Liquidity Opportunity Vehicle, Inc.

www.aldabra4.com

Stephen Schifrin

[email protected]

View original content:https://www.prnewswire.com/news-releases/aldabra-4-liquidity-opportunity-vehicle-inc-announces-pricing-of-261-million-initial-public-offering-302667406.html

SOURCE Aldabra 4 Liquidity Opportunity Vehicle, Inc.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AT&T Enters Over $1 Billion Purchase Agreement With Corning
AT&T Enters Over $1 Billion Purchase Agreement With Corning
Nov 3, 2024
08:47 AM EDT, 10/28/2024 (MT Newswires) -- AT&T ( T ) said Monday it has extended its collaboration with Corning (GLW) with the signing of a multi-year purchase agreement for the supply of fiber, cable, and connectivity products for AT&T's ( T ) fiber network across the United States. The agreement is valued at more than $1 billion, AT&T (...
High Flood Scores Seen For Municipal Bond Offerings This Week
High Flood Scores Seen For Municipal Bond Offerings This Week
Nov 3, 2024
09:11 AM EDT, 10/28/2024 (MT Newswires) -- Multiple municipal bond offerings this week have a high exposure to climate risk, specifically high Flood Scores, according to ICE Climate Data. A $26 million offering from Margate, N.J., records a Flood Score of 5.0 out of 5.0, ICE reports. Locations with a component Physical Climate Risk Score, which includes Flood, Wildfire and...
Porch Group Receives License Approval to Form New Insurance Reciprocal Exchange; Shares Up Pre-Bell
Porch Group Receives License Approval to Form New Insurance Reciprocal Exchange; Shares Up Pre-Bell
Nov 3, 2024
09:12 AM EDT, 10/28/2024 (MT Newswires) -- Porch Group ( PRCH ) said Monday the Texas Department of Insurance approved its application to form and license a new insurance reciprocal exchange. Porch said it will contribute $10 million cash in exchange for a surplus note to capitalize Porch Insurance Reciprocal Exchange after the regulator completes administrative closing procedures. The company...
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
Nov 3, 2024
Monte Rosa Therapeutics Inc ( GLUE ) stock is trading higher on Monday after the company announced a global exclusive development and commercialization license agreement with Novartis AG ( NVS ) to advance VAV1 MGDs, including MRT-6160. MRT-6160 is currently in an ongoing Phase 1, single ascending dose (SAD)/multiple ascending dose (MAD) healthy volunteer study for immune-mediated conditions. Also Read:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved